№ 2021/3

1. European Commission, Pharmaceutical Committee (2020). Dependency of the EU pharmaceutical industry on active pharmaceutical ingredients and chemical raw materials imported from third countries. ec.europa.eu. Retrieved from ec.europa.eu/health/sites/health/files/files/committee/ev_20200312_795_en.pdf
2. Salikhova, O.B. Honcharenko D.O. (2020). Ukraine's Pharmaceuticals: From Dependence to Endogenous Development. Ekon. prognozuvannâ – Economy and forecasting, 4, 7-35. doi.org/10.15407/eip2020.04.007 [in Ukrainian].
3. Open Appeal of the Association «Manufacturers of Medicines of Ukraine» to the President, Prime Minister, other high-ranking officials. Retrieved from ua.interfax.com.ua/news/press-release/651870.html
4. Chernykh, V. (2002) Pharmaceutical industry for the years of independence of Ukraine. Visnyk farmatsiyi – Herald of pharmacy, 3, 3-12 [in Ukrainian].
5. Hroshovyi, T., Pidhirnyi, V., Tryhubchak, O. (2011) Some issues of development of pharmaceutical branch of Ukraine. Zbirnyk prats' Ternopil's'koho oseredku Naukovoho tovarystva imeni Shevchenka – Collection of works of the Ternopil branch of the Scientific Society named after Shevchenko, 6, 154-172 [in Ukrainian].
6. Chomenko, V.N. (2008) Theoretical basis and implementation of modern principles of state pharmacy in Ukraine: avtoref. dys ... Dr in Pharm. Sciences : 15.00.01. Kharkiv [in Ukrainian].
7. Dorovskyi, O.V. (2015). Justification of the Choice of Strategy for the Development of the Pharmaceutical Industry of Ukraine: avtoref. dys ... Dr. in Economics: 08.00.03. Kharkiv [in Ukrainian].
8. Karamyshev, D.V., Sotnikova, L.V. (2021) Implementation of Ukraine’s State policy on the supply of medicines in the context of integration into the European Union. Teoriya ta praktyka derzhavnoho upravlinnya – Theory and practice of public administration, 1(72), 145-157 [in Ukrainian].
9. Sidenko, V.R. (2001) Conceptual foundations of Ukrainian Eurointegration strategy. Ekon. prognozuvannâ – Economy and forecasting, 2, 26-41 [in Ukrainian].
10. Kindzerskyi, Yu.V. (2021) Ukraine's industrial divergence with the EU and problems of it overcoming. Ekonomika ta derzhava – economy and state, 6, 9-18. doi.org/10.32702/2306-6806.2021.6.9 [in Ukrainian].
11. Korablin, S.О. (2021) Government Regulation As A Factor In Counteracting Covid-19. Ekonomika Ukrainy – Economy of Ukraine, 7, 27-40. doi.org/10.15407/economyukr.2021.07.027 [in Ukrainian].
12. Salikhova, O.B. (2021). Localization of pharmaceutical production in Europe as a response to growing external dependence. In Perspectives for post-coronavirus economic transformations and their impact on the development of countries. The place of Ukraine in the post-crisis world (p. 118-124). Kyiv: Zapovit [in Ukrainian].
13. Salikhova, O.B. Comparative advantages of national pharmaceutical industries through the prism of new indicators. Statystyka Ukrainy – Statistics of Ukraine, 2-3, 48-58. doi.org/10.31767/su.2-3(89-90)2020.02-03.06 [in Ukrainian].
14. EU unveils strategy to reduce dependency on China Retrieved from www.eiu.com/n/eu-unveils-strategy-to-reduce-dependency-on-china/
15. EC (2020, October 2). Special meeting of the European Council - Conclusions. Retrieved from www.consilium.europa.eu/media/45910/021020-euco-final-conclusions.pdf
16. Gereffi, G. (2017). The Pharmaceutical Industry and Dependency in the Third World. Princeton University Press.
17. Salikhova, O.B., and Honcharenko, D.O. (2020). Pharmaceutical industry of Mexico: a lesson for Ukraine. Zovnishnia torhivlia: ekonomika, finansy, pravo – Foreign trade: economy, finances, right, 7, 47-69 [in Ukrainian].
18. Chamarik, S. (1994). Goonatilake S.Technological independence - The Asian experience. The United Nations University. Retrieved from digitallibrary.un.org/record/177101
19. Woher kommen unsere Wirkstoffe? (2020, September). Eine Weltkarte der API-Produktion. Kurzreport. Pro Generika. Berlin [in German].
20. Arnum, Р. The EU’s API Supply Chain Under Focus. Retrieved from www.dcatvci.org/7143-the-eu-s-api-supply-chain-under-focus
21. Commission communication to the Council and Parliament on the outlines of an industrial policy for the pharmaceutical sector in the European Community (1994, March 2). COM (93) 718. Retrieved from op.europa.eu/mt/publication-detail/-/publication/6af1ca21-939d-11e9-9369-01aa75ed71a1/language-en/format-PDF/source-search
22. Council Resolution designed to implement the outlines of an industrial policy in the pharmaceutical sector in the European Union (1996). Retrieved from op.europa.eu/ga/publication-detail/-/publication/bf15f43c-6a8b-4953-8155-04fc004a1be3/language-en
23. EC, Commission Staff Working Document (2014). Pharmaceutical Industry: A Strategic Sector for the European Economy. etrieved from ec.europa.eu/growth/content/pharmaceutical-industry-strategic-sector-european-economy-0_en
24. Affordable, accessible and safe medicines for all: the Commission presents a Pharmaceutical Strategy for Europe. Retrieved from ec.europa.eu/commission/presscorner/detail/en/ip_20_2173
25. Updating the 2020 Industrial Strategy: towards a stronger Single Market for Europe's recovery. Retrieved from ec.europa.eu/commission/presscorner/detail/en/IP_21_1884
26. EU research and innovation in action against the coronavirus: funding, results and impact. Retrieved from ec.europa.eu/info/sites/default/files/research_and_innovation/research_by_area/documents/ec_rtd_eu-research-innovation-against-covid.pdf
27. INNO4COV-19 - Boosting Innovations for COVID-19 Diagnostic, Prevention and Surveillance. Retrieved from idw-online.de/de/news757837
28. EU Strategy for COVID-19 vaccines. Brussels (2020, July17). COM(2020) 245 final. Communication From The Commission To The European Parliament, The European Council, The Council And The European Investment Bank. Retrieved from eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52020DC0245&from=EN
29. Safe COVID-19 vaccines for Europeans. Retrieved from ec.europa.eu/info/live-work-travel-eu/coronavirus-response/safe-covid-19-vaccines-europeans_en#check-the-facts
30. COVID-19 Therapeutics Strategy: Commission identifies five promising candidate therapeutics. Retrieved from ec.europa.eu/commission/presscorner/detail/en/ip_21_3299
31. Dujun (Honcharenko), D.О. (2016) Threats of the pharmaceutical production of Ukraine in the context of the analysis of foreign trade in high-technology goods. Problemy nauky – Problems of science, 2, 23-33 [in Ukrainian].
32. Recommendations of the Committee hearing of June 15, 2016 "Legislative Support for the Development of the National Innovation System: State and Solutions" (2016, June 15). Approved by the decision of the Verkhovna Rada Committee on Science and Education of 6 July 2016, Protocol 46. Retrieved from kno.rada.gov.ua/news/Robota_Kom/Parl_Kom_slukh/Kom_slukh/8_skl/74403.html [in Ukrainian].
33. Draft Concept of the State Target Programme Development of Import-substituting Industries in Ukraine and Substitution of Imported Medicines with Domestic Preparations, including Biotechnological Preparations and Vaccines for 2011-2021. Retrieved from www.apteka.ua/article/78579 [in Ukrainian].
34. Honcharenko, D.O. (2021). Development of pharmaceuticals of Ukraine in the conditions of European integration: principles, events, priorities. Integration of scientific research and development in practical activity: collection of materials of the III of the All-Ukrainian Multidisciplinary Scientific and Practical Internet Conference, June 30, 2021, Kharkiv (p. 30-38). Kyiv: Jarochenko Ja.V. doi.org/10.51500/7826-09-4 [in Ukrainian].
35. The concept of the development of import-substituting industries - a threat to the pharmaceutical industry and to the security of the population of Ukraine. Retrieved from ua.interfax.com.ua/news/press-release/68941.html [in Ukrainian].
36. The results of the implementation of the State scientific and technical programme for the development of the latest technologies for the creation of indigenous medicines in 2012 were summarized. Retrieved from www.apteka.ua/article/201885 [in Ukrainian].
37. Korj, B. Foundation at COVID-19: How used Coronavirus Money. Retrieved from voxukraine.org/fond-na-covid-19-yak-vikoristali-koronavirusni-groshi/ [in Ukrainian].
38. Draft Order of the Cabinet of Ministers of Ukraine "On approval of the Concept of the State Target Programme for the Creation and Development of the Internal Production of High-Quality Medicines for the Prevention and Treatment of Particularly Dangerous Infectious and Other Diseases in order to meet the State needs of Ukraine for the period 2021-2026. Retrieved from moz.gov.ua/ [in Ukrainian].
39. NAS of Ukraine (2021, June 9). Meeting of the Presidium of the NAS of Ukraine. Retrieved from www.nas.gov.ua/UA/Messages/Pages/View.aspx?MessageID=7891 [in Ukrainian].
40. Adoption of the National Economic Strategy 2030 (2021, March 3). Resolution of the Cabinet of Ministers of Ukraine 179. Retrieved from www.kmu.gov.ua/npas/pro-zatverdzhennya-nacionalnoyi-eko-a179 [in Ukrainian].
41. Simonov, D. Almost like going to Mars.
Could Ukraine develop its own coronavirus vaccine. Retrieved from hromadske.ua/posts/majzhe-yak-polit-na-mars-chi-mozhe-ukrayina-stvoriti-vlasnu-vakcinu-proti-koronavirusu [in Ukrainian].
42. There is a capacity to produce a vaccine against COVID in Ukraine – developers. Retrieved from www.radiosvoboda.org/a/meyemo-potuzhnosti-aby-vyhotovliaty-vaksinu-proty-covid-v-ukraini/30917997.html [in Ukrainian].
43. Salikhova, O.B., and Honcharenko, D.O. (2020). Politics of development of pharmaceutical industry in Germany: Lessons for Ukraine. Ekonomika Ukrainy – Economy of Ukraine, 10, 63-86. doi.org/10.15407/economyukr.2020.10.063 [in Ukrainian].
44. Honcharenko, D.O. (2021). The Theoretical Approaches and Methodological Principles for Development of Ukrainian Pharmaceutical Production in the Conditions of European Integration. Biznes Inform – Business Inform, 5, 194-201. doi.org/10.32983/2222-4459-2021-5-194-201 [in Ukrainian].
45. Salikhova, O.B., Honcharenko, D.O. (2020). The Conceptual Foundations of the Strategy of Development of the High-Tech Industry of Pharmaceuticals and Medical Products in Ukraine till 2030. Biznes Inform – Business Inform, 7, 28-35. doi.org/10.32983/2222-4459-2020-7-28-35 [in Ukrainian].
46. Salikhova, O.B., and Honcharenko, D.O. (2020). The Pharmaceutical Industry of France. Zovnishnia torhivlia: ekonomika, finansy, pravo – Foreign trade: economy, finances, right, 2, 67-84. doi.org/10.31617/zt.knute.2020(109)05 [in Ukrainian].